Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States.
It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. It also operates as a biotech research development company. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
Company profile from EODHD, stored Oct 29, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 13, 2026 | — | — | — | -$1.2M | -$1.2M |
| Mar 2026filed May 14, 2026 | — | — | — | -$798.5K | -$810.8K |
| Dec 2025filed Mar 12, 2026 | — | — | — | -$609.7K | -$656.9K |
| Sep 2025filed Nov 12, 2025 | — | — | — | -$527.9K | -$472.5K |
| Jun 2025filed Aug 14, 2025 | — | — | — | -$1.7M | -$1.0M |
| Mar 2025filed May 19, 2025 | $61.5K | -43.9% | 50.0% | -$1.3M | -$6.1M |
| Dec 2024 | — | — | — | -$1.2M | -$1.5M |
| Sep 2024filed Nov 14, 2024 | — | — | — | -$4.5M | -$4.9M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 12, 2026 | — | — | — | -$4.2M | -$8.3M |
| Dec 2024filed Apr 8, 2025 | — | — | — | -$19.3M | -$13.2M |
| Dec 2023filed Jun 25, 2024 | — | — | — | -$48.4M | -$48.9M |
| Dec 2022filed Apr 10, 2023 | — | — | — | -$45.5M | -$42.2M |
| Dec 2021filed Apr 8, 2022 | — | — | — | -$30.4M | -$32.7M |
| Dec 2020filed Mar 31, 2021 | — | — | — | -$20.1M | -$20.4M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched HEPA. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
3,854 shares short
-11,008 shares (-74.1%) vs Sep 30, 2026
0% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
14,862 shares short
+10,046 shares (+208.6%) vs Sep 15, 2026
0% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
4,816 shares short
+1,336 shares (+38.4%) vs Aug 31, 2026
0% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
3,480 shares short
-15,968 shares (-82.1%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
19,448 shares short
+17,981 shares (+1,225.7%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
1,467 shares short
-7,560 shares (-83.7%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind HEPA’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 50 · reverse split
Effective Mar 18, 2025
Each 50 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective May 11, 2023
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
1 for 70 · reverse split
Effective Jun 3, 2019
Each 70 pre-split shares become 1 post-split share.
Source: EODHD
1 for 8 · reverse split
Effective May 29, 2018
Each 8 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if HEPA is in your portfolio and how much it contributes.
Sign inLoading market dates
0 smart-money holders: institutions with a high Holder IQ
Sentiment: bullish
Last trade: buy 36 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 12
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.